Search Market Research Report

Discover Our Latest Reports
Discover Our Featured Reports
Discover Top Selling Reports

Hyaluronidase Market Size, Share Global Analysis Report, 2019–2026

report img

Hyaluronidase Market By Type (Animal-derived Hyaluronidase and Synthetic Hyaluronidase) and By Application (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery and Others): Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecast 2019–2026

Industry Insights

[189+ Pages Report] According to the report published by Facts Factors, the global hyaluronidase market size was worth around USD 733.7 million in 2019 and is predicted to grow to around USD 1293.4 million by 2026 with a compound annual growth rate (CAGR) of roughly 8.0% between 2020 and 2026. The report analyzes the global hyaluronidase market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the hyaluronidase market.
Hyaluronidase Market Size

To know more about this report | Request Free Sample Copy

This professional and specialized report study examines the technical and business perspective of the Hyaluronidase industry. The report provides a historical analysis of the industry as well as the projected trends expected to be witnessed in the Hyaluronidase Market. The report study analyzes the market statistics at the global as well as regional levels to gain an in-depth perspective of the overall hyaluronidase market.

The historical insights are provided from 2016 to 2019 and projected trends are provided from 2020 to 2026. The quantitative data is provided in terms of both volumes (Units) and value (USD Million) for 2016 – 2026. The qualitative data is reinforced by analyzing and providing numerous market dynamics (directly or indirectly affecting the industry) such as growth drivers, restraints, challenges, and opportunities.


logoKey Insights from Primary Research

  • Our primary respondents believe the market to witness a rapid growth of 8.0% over the forecast period on account of rising environmental concerns.
  • Some of the CXOs predict the Animal-derived Hyaluronidase segment to maintain its dominance throughout 2026 as Animal-derived Hyaluronidase provides a most effective process of absorption of other injected fluids in the body. Furthermore, the manufacturers operating in this market are expanding their presence through mergers and acquisitions across various industry verticals.
  • Some of the industry experts interviewed in the Asia Pacific revealed that increasing awareness of skin care and body alteration surgeries has propelled the growth of the Hyaluronidase market globally.
  • Regionally, the Asia Pacific region is expected to contribute largely to the global Hyaluronidase market. Some of the interviewees said that their future plans are to focus majorly on Hyaluronidase application areas. The manufacturers operating in countries such as the U.S. and Canada are expected to create higher adoption opportunities for the Hyaluronidase market.
  • The information & technology subject matter experts suggest investing in R&D activities to come up with newer, economic, and more efficient Hyaluronidase. They believe advanced technology in the medical and chemical industry will witness widespread acceptance across the value chain of the Hyaluronidase market.

logoKey Recommendations from Analysts

  • Our analysts recommend focusing on the Asia Pacific Hyaluronidase market since their calculations revealed that this region turned out to be the top investment pocket across the globe owing to greater opportunities in emerging countries such as India and China.
  • The major reason behind the upsurge in growth and lucrative opportunities underlying in this region is the introduction of affordable medical schemes by various government organizations across the globe.
  • North America, on the other hand, is expected to foresee robust growth accounting for USD 255.5 Mn in 2019. This is majorly attributed to rising high medical services across the U.S. and Canada.
  • The strategic mergers and acquisitions by key industry players and high demand across application areas is anticipated to fuel the market growth
  • The executive summary of the report reads the total opportunity underlying in the global Hyaluronidase market is nearly USD 1293.4 Mn between 2020 and 2026.

logoHyaluronidase – Cost Structure

Hyaluronidase Market

To know more about this report | Request Free Sample Copy


We have included various industry analysis models in our report and extensively demonstrated the key business strategies and competitive landscape of the Hyaluronidase Market in our study.

Our study also includes an analysis of Porter’s Five Forces framework for understanding the competitive strategies adopted by various stakeholders involved in the entire value chain of the Hyaluronidase Market. It also encompasses PESTLE analysis and SWOT analysis.

The report also offers an in-depth analysis of the market shares of each industry player and gives an outline of the market position of key players in the Hyaluronidase Market. Moreover, the study offers wide coverage of key strategic advances witnessed in the market such as new product launches, acquisitions & mergers, collaborations & joint ventures, funding & VC activities, agreements, partnerships, R&D activities, and regional expansion of key players of the Hyaluronidase Market.

The research study provides a critical assessment of the Hyaluronidase industry by logically segmenting the market on the basis of product type, connectivity, port, distribution channel and regions. Based on the past, present, and future trends, all the segments were analyzed from the bottom up, and the market sizes have been estimated from 2020 to 2026. The regional segmentation of the Hyaluronidase industry includes the holistic bifurcation of all the five major continents including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Hyaluronidase for medical use was firstly obtained from crude extracts of bovine or ovine testicular tissue called BTH (bovine testicular Hyaluronidase). Hyaluronidase is employed for medical practice to upsurge tissue absorption of numerous drugs. The prime application of Hyaluronidase is to increase the capacity of absorption of injected drug. In dermatology and plastic surgery Hyaluronidase are usually used to enhance the effects of local anesthetics and to dissolve the injected Hyaluronidase. Hyaluronidase is most commonly used to treat cosmetic disorders, dehydration, muscle stiffness and others.

logoReport Scope

Report Attribute

Details

Market Size in 2019

USD 733.7 Million

Projected Market Size in 2026

USD 1293.4 Million

CAGR Growth Rate

8.0% CAGR

Base Year

2019

Forecast Years

2020-2026

Key Market Players

Amphastar Pharmaceuticals, Inc., Halozyme, Inc., Bausch & Lomb Incorporated, The Cooper Companies Inc., Sun Pharmaceutical Industries Ltd., STEMCELL Technologies Inc., Shreya Life Sciences Pvt. Ltd., Calzyme, and Others

Key Segment

By Type, Application, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs.Explore purchase options

Increasing penetration of Hyaluronidase across different application areas such as chemotherapy, cosmetic surgery, and others has driven the market growth of Hyaluronidase globally. The market has witnessed growth owing to the raising need for physical alterations among the millennial population across the globe. The need for safe and side effect-free cosmetic surgery requirements has propelled the growth of the Hyaluronidase market over the forecast period.

The Hyaluronidase Market is categorized by product type, and by application. On the basis of product, the market is divided into Animal-derived Hyaluronidase and Synthetic Hyaluronidase. By Application, the market is further divided into Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, and Others.

logoSome of the key players operating in the Hyaluronidase Market around the globe include

  •  Amphastar Pharmaceuticals Inc.
  •  Halozyme Inc.
  •  Bausch & Lomb Incorporated
  •  the Cooper Companies Inc.
  •  Sun Pharmaceutical Industries Ltd.
  •  STEMCELL Technologies Inc.
  •  Shreya Life Sciences Pvt. Ltd.
  •  Calzyme

The taxonomy of the Hyaluronidase industry by its scope and segmentation is as follows:

logo By Type Segmentation Analysis

  • Animal-derived Hyaluronidase
  • Synthetic Hyaluronidase

logo By Application Segmentation Analysis

  • Dermatology
  • Chemotherapy
  • Ophthalmology
  • Plastic Surgery
  • Others

logo By Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

logoKEY BUSINESS POINTERS ADDRESSED & FOREMOST REASONS TO PROCURE THE REPORT:

  • Statistical Analysis of the Past, Current, and Future Trends of the Industry with Validated Market Sizes Data
  • Direct and Indirect Rationales Impacting the Industry
  • In-depth and Micro Analysis of Viable Segments and Sub-segments
  • Companies and Vendors Market Share, Competitive Landscape, and Player Positioning Analysis
  • Demand Side (Consumption) and Supply Side (Production) Perspective and Analysis wherever applicable
  • Key Buyers and End-Users Analysis
  • Value Chain and Manufacturing Cost Structure Analysis wherever relevant
  • Key Marketing Strategies as well as Key Sales Channels adopted in the market
  • Investment Opportunity Analysis & Patents Analysis wherever feasible
  • Technological Road Map & Technical Analysis
  • Robust Research Methodology comprising dynamic mix (65%~35%) of Extensive Primary Research (primary interviews, ad-hoc surveys, questionnaires) and Protracted Secondary Research (proprietary in-house database, paid external databases, publically available validated sources)

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Hyaluronidase market – Type Analysis
    1. 2.1. Global Hyaluronidase Market – Type Overview
    2. 2.2. Global Hyaluronidase Market Share, by Type, 2018 & 2025 (USD Million)
    3. 2.3. Animal-derived Hyaluronidase
      1. 2.3.1. Global Animal-derived Hyaluronidase Hyaluronidase Market, 2016-2026 (USD Million)
    4. 2.4. Synthetic Hyaluronidase
      1. 2.4.1. Global Synthetic Hyaluronidase Hyaluronidase Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Hyaluronidase market – Application Analysis
    1. 3.1. Global Hyaluronidase Market – Application Overview
    2. 3.2. Global Hyaluronidase Market Share, by Application, 2018 & 2025 (USD Million)
    3. 3.3. Dermatology
      1. 3.3.1. Global Dermatology Hyaluronidase Market, 2016-2026 (USD Million)
    4. 3.4. Chemotherapy
      1. 3.4.1. Global Chemotherapy Hyaluronidase Market, 2016-2026 (USD Million)
    5. 3.5. Ophthalmology
      1. 3.5.1. Global Ophthalmology Hyaluronidase Market, 2016-2026 (USD Million)
    6. 3.6. Plastic Surgery
      1. 3.6.1. Global Plastic Surgery Hyaluronidase Market, 2016-2026 (USD Million)
    7. 3.7. Others
      1. 3.7.1. Global Others Hyaluronidase Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Hyaluronidase market – Regional Analysis
    1. 4.1. Global Hyaluronidase Market Regional Overview
    2. 4.2. Global Hyaluronidase Market Share, by Region, 2018 & 2025 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Hyaluronidase Market size and forecast, 2016-2026
      2. 4.3.2. North America Hyaluronidase Market, by Country, 2018 & 2025 (USD Million)
      3. 4.3.3. North America Hyaluronidase Market, by Type, 2016-2026
      4. 4.3.4. North America Hyaluronidase Market, by Application, 2016-2026
      5. 4.3.5. U.S.
      6. 4.3.6. Canada
    4. 4.4. Europe
      1. 4.4.1. Europe Hyaluronidase Market size and forecast, 2016-2026
      2. 4.4.2. Europe Hyaluronidase Market, by Country, 2018 & 2025 (USD Million)
      3. 4.4.3. Europe Hyaluronidase Market, by Type, 2016-2026
      4. 4.4.4. Europe Hyaluronidase Market, by Application, 2016-2026
      5. 4.4.5. Germany
      6. 4.4.6. France
      7. 4.4.7. U.K.
      8. 4.4.8. Italy
      9. 4.4.9. Spain
      10. 4.4.10. Rest of Europe
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Hyaluronidase Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Hyaluronidase Market, by Country, 2018 & 2025 (USD Million)
      3. 4.5.3. Asia Pacific Hyaluronidase Market, by Type, 2016-2026
      4. 4.5.4. Asia Pacific Hyaluronidase Market, by Application, 2016-2026
      5. 4.5.5. China
      6. 4.5.6. Japan
      7. 4.5.7. India
      8. 4.5.8. South Korea
      9. 4.5.9. South-East Asia
      10. 4.5.10. Rest of Asia Pacific
    6. 4.6. Latin America
      1. 4.6.1. Latin America Hyaluronidase Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Hyaluronidase Market, by Country, 2018 & 2025 (USD Million)
      3. 4.6.3. Latin America Hyaluronidase Market, by Type, 2016-2026
      4. 4.6.4. Latin America Hyaluronidase Market, by Application, 2016-2026
      5. 4.6.5. Brazil
      6. 4.6.6. Mexico
      7. 4.6.7. Rest of Latin America
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Hyaluronidase Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Hyaluronidase Market, by Country, 2018 & 2025 (USD Million)
      3. 4.7.3. The Middle-East and Africa Hyaluronidase Market, by Type, 2016-2026
      4. 4.7.4. The Middle-East and Africa Hyaluronidase Market, by Application, 2016-2026
      5. 4.7.5. GCC Countries
      6. 4.7.6. South Africa
      7. 4.7.7. Rest of Middle-East Africa
  5. CHAPTER 5. Hyaluronidase market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. Amphastar Pharmaceuticals, Inc.
      1. 6.1.1. Company Overview
      2. 6.1.2. Amphastar Pharmaceuticals, Inc. Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Halozyme, Inc.
      1. 6.2.1. Company Overview
      2. 6.2.2. Halozyme, Inc. Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Bausch & Lomb Incorporated
      1. 6.3.1. Company Overview
      2. 6.3.2. Bausch & Lomb Incorporated Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. The Cooper Companies Inc.
      1. 6.4.1. Company Overview
      2. 6.4.2. The Cooper Companies Inc. Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Sun Pharmaceutical Industries Ltd.
      1. 6.5.1. Company Overview
      2. 6.5.2. Sun Pharmaceutical Industries Ltd. Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. STEMCELL Technologies Inc.
      1. 6.6.1. Company Overview
      2. 6.6.2. STEMCELL Technologies Inc. Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Shreya Life Sciences Pvt. Ltd.
      1. 6.7.1. Company Overview
      2. 6.7.2. Shreya Life Sciences Pvt. Ltd. Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. Calzyme
      1. 6.8.1. Company Overview
      2. 6.8.2. Calzyme Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
  7. CHAPTER 7. Hyaluronidase — Industry Analysis
    1. 7.1. Hyaluronidase Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Hyaluronidase Market – Attractiveness Analysis
      1. 7.4.1. By Type
      2. 7.4.2. By Application
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models

  • List of Figures

    FIG. 1 Global Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 2 Global Hyaluronidase Market Share, by Type, 2018 & 2025 (USD Million)
    FIG. 3 Global  Animal-derived Hyaluronidase Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 4 Global Synthetic Hyaluronidase Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 5 Global Hyaluronidase Market Share, by Application, 2018 & 2025 (USD Million)
    FIG. 6 Global Dermatology Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 7 Global Chemotherapy Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 8 Global Ophthalmology Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 9 Global Plastic Surgery Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 10 Global Others Hyaluronidase Market, 2016-2026 (USD Million)
    FIG. 11 Global Hyaluronidase Market Share, by Region, 2018 & 2025
    FIG. 12 North America Hyaluronidase Market, 2016-2026
    FIG. 13 U.S. Hyaluronidase Market, 2016-2026
    FIG. 14 Canada Hyaluronidase Market, 2016-2026
    FIG. 15 Europe Hyaluronidase Market, 2016-2026
    FIG. 16 Germany Hyaluronidase Market, 2016-2026
    FIG. 17 France Hyaluronidase Market, 2016-2026
    FIG. 18 U.K. Hyaluronidase Market, 2016-2026
    FIG. 19 Italy Hyaluronidase Market, 2016-2026
    FIG. 20 Spain Hyaluronidase Market, 2016-2026
    FIG. 21 Rest of Europe Hyaluronidase Market, 2016-2026
    FIG. 22 Asia Pacific Hyaluronidase Market, 2016-2026
    FIG. 23 China Hyaluronidase Market, 2016-2026
    FIG. 24 Japan Hyaluronidase Market, 2016-2026
    FIG. 25 India Hyaluronidase Market, 2016-2026
    FIG. 26 South  Korea Hyaluronidase Market, 2016-2026
    FIG. 27 South-East Asia Hyaluronidase Market, 2016-2026
    FIG. 28 Rest of Asia Pacific Hyaluronidase Market, 2016-2026
    FIG. 29 Latin America Hyaluronidase Market, 2016-2026
    FIG. 30 Brazil Hyaluronidase Market, 2016-2026
    FIG. 31 Mexico Hyaluronidase Market, 2016-2026
    FIG. 32 Rest of Latin America Hyaluronidase Market, 2016-2026
    FIG. 33 The Middle-East and Africa Hyaluronidase Market, 2016-2026
    FIG. 34 GCC Countries Hyaluronidase Market, 2016-2026
    FIG. 35 South Africa Hyaluronidase Market, 2016-2026
    FIG. 36 Rest of Middle-East Africa Hyaluronidase Market, 2016-2026
    FIG. 37 Competitor Market Share – Revenue
    FIG. 38 Amphastar Pharmaceuticals, Inc. Revenue and Growth Rate
    FIG. 39 Amphastar Pharmaceuticals, Inc. Market Share
    FIG. 40 Halozyme, Inc. Revenue and Growth Rate
    FIG. 41 Halozyme, Inc. Market Share
    FIG. 42 Bausch & Lomb Incorporated Revenue and Growth Rate
    FIG. 43 Bausch & Lomb Incorporated Market Share
    FIG. 44 The Cooper Companies Inc. Revenue and Growth Rate
    FIG. 45 The Cooper Companies Inc. Market Share
    FIG. 46 Sun Pharmaceutical Industries Ltd. Revenue and Growth Rate
    FIG. 47 Sun Pharmaceutical Industries Ltd. Market Share
    FIG. 48 STEMCELL Technologies Inc. Revenue and Growth Rate
    FIG. 49 STEMCELL Technologies Inc. Market Share
    FIG. 50 Shreya Life Sciences Pvt. Ltd. Revenue and Growth Rate
    FIG. 51 Shreya Life Sciences Pvt. Ltd. Market Share
    FIG. 52 Calzyme Revenue and Growth Rate
    FIG. 53 Calzyme Market Share
    FIG. 54 Market Dynamics
    FIG. 55 Global Hyaluronidase – Value Chain Analysis
    FIG. 56 Technology Roadmap and Timeline
    FIG. 57 Market Attractiveness Analysis – By Type
    FIG. 58 Market Attractiveness Analysis – By Application
    FIG. 59 Market Attractiveness Analysis – By Region
    FIG. 60 Market Channel
    FIG. 61 Marketing Channel Development Trend
    FIG. 62 Growth in World Gross Product, 2008-2018
    

    List of Tables

    TABLE 1 Global Hyaluronidase Market, 2018 & 2025 (USD Million)
    TABLE 2 Global Hyaluronidase market, by Type, 2016-2026 (USD Million)
    TABLE 3 Global Hyaluronidase market, by Application, 2016-2026 (USD Million)
    TABLE 4 Global Hyaluronidase market, by Region, 2016-2026 (USD Million)
    TABLE 5 North America Hyaluronidase Market, by Type, 2016-2026 (USD Million)
    TABLE 6 North America Hyaluronidase Market, by Application, 2016-2026 (USD Million)
    TABLE 7 Europe Hyaluronidase Market, by Type, 2016-2026 (USD Million)
    TABLE 8 Europe Hyaluronidase Market, by Application, 2016-2026 (USD Million)
    TABLE 9 Asia Pacific Hyaluronidase Market, by Type, 2016-2026 (USD Million)
    TABLE 10 Asia Pacific Hyaluronidase Market, by Application, 2016-2026 (USD Million)
    TABLE 11 Latin America Hyaluronidase Market, by Type, 2016-2026 (USD Million)
    TABLE 12 Latin America Hyaluronidase Market, by Application, 2016-2026 (USD Million)
    TABLE 13 The Middle-East and Africa Hyaluronidase Market, by Type, 2016-2026 (USD Million)
    TABLE 14 The Middle-East and Africa Hyaluronidase Market, by Application, 2016-2026 (USD Million)
    TABLE 15 Global Hyaluronidase Market - Company Revenue Analysis 2016-2019 (USD Million)
    TABLE 16 Global Hyaluronidase Market - Company Revenue Share Analysis 2016-2019(%)
    TABLE 17 Acquisitions and Mergers
    TABLE 18 New Product/Service Launch
    TABLE 19 Research & Development Activities
    TABLE 20 Market Drivers
    TABLE 21 Market Restraints
    TABLE 22 Market Opportunities
    
    
  •  

    Industry Major Market Players

    •  Amphastar Pharmaceuticals Inc.
    •  Halozyme Inc.
    •  Bausch & Lomb Incorporated
    •  the Cooper Companies Inc.
    •  Sun Pharmaceutical Industries Ltd.
    •  STEMCELL Technologies Inc.
    •  Shreya Life Sciences Pvt. Ltd.
    •  Calzyme